CIMG Inc.

CIMG Inc. is a business group focused on digital health and sales development, integrating a cryptocurrency-focused strategy. The company leverages artificial intelligence (AI) and cryptocurrencies, including Bitcoin and stablecoins, to foster business growth, maximize user acquisition, and enhance brand management value for its clients. CIMG Inc. is headquartered in Tuen Mun, Hong Kong, and is committed to bridging the gap between traditional finance and the cryptocurrency world to generate composite growth value for its shareholders through innovative financial management and advanced technological applications.

Initially, CIMG Inc. engaged in the consumer food and beverage sector, offering products such as maca peptide coffee, noni, purified powder, and wine, under brands like Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango. The company has since expanded its offerings to include advanced marketing solutions, utilizing marketing technology and multi-channel networks. More recently, CIMG Inc. has strategically diversified into the computing power industry, providing equipment and services. It also pursues strategic partnerships in digital asset infrastructure and on-chain liquidity services, notably with entities like iZUMi Finance, Bedrock, and Quack AI.

In a significant strategic shift, CIMG Inc. has increasingly focused on the computing power industry, securing substantial contracts, including a $106.5 million agreement in December 2025 and additional contracts totaling millions in early 2026. The company has adopted a Digital Asset Treasury (DATs) strategy, holding Bitcoin as a long-term treasury asset, and had acquired 730 Bitcoins by October 2025. Led by CEO Jianshuang Wang and President Wenlong Tong, CIMG Inc. is a micro-cap company that was formerly listed on Nasdaq under the ticker IMG but was suspended and currently trades on OTC Markets under CIMG, while appealing its delisting from Nasdaq.

Latest updates

CIMG Inc. Revenue Surges as Digital Health and Computing Power Ventures Expand

Event summary

  • CIMG Inc. reported total revenue of $15.77 million for Q1 2025, a significant increase from $22,853 in the prior-year period.
  • As of December 31, 2025, CIMG held 730 Bitcoins with a carrying value of $63.98 million.
  • The company expanded its operations with new subsidiaries in Shenzhen and Foshan, China, and acquired Braincon Limited and its subsidiary.
  • CIMG generated revenue from computing power products through contracts with enterprise customers, including China Merchants Bank, following the official launch of the product series in September 2025.

The big picture

CIMG's rapid expansion into medicine-food homology products and computing power solutions represents a significant strategic pivot, moving beyond its initial digital health and sales development focus. The company's substantial Bitcoin holdings introduce a layer of volatility and speculative risk, while its aggressive expansion in the Chinese market exposes it to regulatory and geopolitical uncertainties. The acquisition of Braincon Limited suggests a deliberate effort to strengthen its localized operational capabilities and expand its product offerings within the Asia market.

What we're watching

Nasdaq Compliance
The company's ability to maintain its Nasdaq listing status remains a critical risk, given the ongoing appeal against the delisting decision and the need to rectify past compliance issues. Success hinges on demonstrating adherence to listing requirements and resolving outstanding concerns.
Profitability
While revenue growth is promising, CIMG's ability to improve gross profit margins and transition to sustained profitability will depend on optimizing pricing, controlling costs, and scaling its new product lines effectively.
China Regulatory
Increased scrutiny of CIMG's operations in China, particularly concerning data processing and digital health products, could significantly impact its growth trajectory and necessitate adjustments to its business strategy.

CIMG Explores Institutional DeFi Entry with Bedrock Partnership

Event summary

  • CIMG Inc. and Bedrock have signed a non-binding memorandum of understanding (MOU) to explore a strategic collaboration.
  • The focus is on compliant institutional decentralized finance (DeFi) solutions, specifically Bitcoin (BTC) liquid staking.
  • CIMG will contribute expertise in financial compliance and institutional structuring, while Bedrock provides staking and asset management technology.
  • The MOU is non-binding and requires further negotiations for a definitive agreement.

The big picture

CIMG's foray into institutional DeFi signals a broader trend of traditional financial players seeking to leverage blockchain technology while adhering to regulatory requirements. The focus on BTC liquid staking suggests an attempt to capitalize on the growing demand for yield-generating opportunities within the Bitcoin ecosystem. This partnership represents a relatively early stage effort to bridge the gap between traditional finance and DeFi, a market with potentially significant long-term growth but also considerable regulatory and technological hurdles.

What we're watching

Regulatory Headwinds
The success of this collaboration hinges on navigating evolving regulatory frameworks surrounding institutional DeFi, which could significantly impact the timeline and scope of the partnership.
Execution Risk
Given the non-binding nature of the MOU, there's a risk that definitive agreements won't be reached, or that the envisioned collaboration fails to materialize due to disagreements on project milestones or resource allocation.
Market Adoption
The pace at which traditional financial institutions adopt compliant DeFi solutions will dictate the ultimate value of this partnership, and broader market acceptance of BTC liquid staking remains a key factor.

CIMG Partners with The Ching Labs to Expand Institutional Crypto Infrastructure

Event summary

  • CIMG Inc. (Nasdaq: CIMG) has entered into an agreement with The Ching Labs Ltd. through its subsidiary, CIMG PTE. Ltd.
  • The collaboration focuses on exploring compliant tokenization, on-chain yield opportunities, and decentralized governance within the DeSyn Protocol ecosystem.
  • CIMG intends to evaluate DeSyn's cross-chain liquidity architecture and security model for institutional initiatives.
  • The initiative aims to develop an enterprise-oriented framework for multi-chain asset management and tokenized real-world assets (RWAs).

The big picture

CIMG’s move signals a growing trend of established business groups seeking to leverage DeFi infrastructure to serve institutional clients. The partnership with The Ching Labs addresses the increasing demand for secure and compliant solutions for tokenized assets and structured yield strategies, particularly as institutional adoption of digital assets continues to expand. This collaboration represents a bet on the future of RWA tokenization and its integration into traditional financial systems.

What we're watching

Regulatory Scrutiny
The focus on 'compliant tokenization' suggests CIMG is anticipating increased regulatory oversight of digital asset activities, and the success of this partnership hinges on navigating evolving legal frameworks.
DeSyn Adoption
The pace at which institutional treasuries adopt DeSyn’s architecture will determine the tangible impact on CIMG’s revenue streams and overall strategic positioning.
Execution Risk
Developing an 'enterprise-oriented framework' is complex; the ability of CIMG and The Ching Labs to integrate their technologies and deliver a functional product will be critical to realizing the stated goals.

CIMG Explores AI-Powered Crypto Automation in Partnership with Quack AI

Event summary

  • CIMG Inc. and Quack AI have signed a memorandum of understanding (MOU) to explore a strategic collaboration.
  • The collaboration aims to integrate AI into compliant digital asset and DeFi infrastructure.
  • The focus is on enabling autonomous software agents to perform economic activity and exchange value, particularly in M2M commerce.
  • CIMG will leverage its compliance expertise, while Quack AI contributes AI and machine learning capabilities.
  • The MOU is non-binding and subject to further negotiations and definitive agreements.

The big picture

This MOU signals a growing trend toward the convergence of AI and decentralized finance, aiming to automate complex financial processes and unlock new efficiencies in M2M commerce. The initiative addresses a key challenge in the DeFi space: the need for greater regulatory compliance and institutional-grade security. While the MOU is non-binding, it represents a significant bet on the future of agentic economies and the potential for AI to reshape financial transactions.

What we're watching

Regulatory Scrutiny
The success of this initiative hinges on navigating evolving regulatory frameworks for digital assets and AI, which could significantly impact the scope and viability of the proposed solutions.
Execution Risk
Integrating AI and DeFi infrastructure presents significant technical challenges, and the parties' ability to execute on their vision will determine the partnership's ultimate value.
Adoption Rate
The pace at which institutional clients adopt AI-driven crypto strategies will dictate the revenue potential for both CIMG and Quack AI, and may be limited by concerns around security and governance.

CIMG Explores Digital Asset Expansion Through iZUMi Partnership

Event summary

  • CIMG Inc. and iZUMi Finance have signed a Memorandum of Understanding (MOU) to explore a strategic partnership.
  • The MOU includes potential acquisition of iZUMi assets, patents, and technology by CIMG.
  • CIMG intends to evaluate options for managing its digital asset holdings, including Bitcoin.
  • The partnership aims to focus on digital asset infrastructure and on-chain liquidity services.

The big picture

CIMG's move signals a deepening commitment to leveraging digital assets and blockchain technology within its existing digital health and sales development business model. This partnership represents an attempt to build out its infrastructure and potentially expand its revenue streams beyond its current client base. The deal’s success will depend on CIMG’s ability to navigate the complex regulatory landscape surrounding digital assets and integrate iZUMi’s technology effectively.

What we're watching

Deal Execution
The success of this partnership hinges on negotiating definitive agreements, which could be complicated by differing valuations or strategic priorities between CIMG and iZUMi.
Asset Integration
CIMG's ability to effectively integrate any acquired assets and technology from iZUMi will be crucial to realizing the partnership's strategic goals and avoiding integration risk.
Regulatory Scrutiny
Increased regulatory scrutiny of digital asset acquisitions and on-chain liquidity services could impact the timeline and structure of any potential transaction.

CIMG Inc. Revenue Surges 433% on Computing Power and Digital Health Growth

Event summary

  • CIMG Inc. reported revenue of approximately $10.3 million for fiscal year 2025, a 433% year-over-year increase.
  • The company reduced its net loss by 45.5% year-over-year, attributed to business transformation and cost optimization.
  • As of September 30, 2025, CIMG held approximately 500 Bitcoins valued at $57.05 million.
  • CIMG's total assets increased by approximately 1,227% year-over-year, largely due to its digital asset holdings.
  • The company focused on AI computing infrastructure and digital health as core growth sectors.

The big picture

CIMG's rapid revenue growth and strategic pivot towards AI computing and digital health highlight the increasing convergence of these sectors. The company’s significant Bitcoin holdings represent a high-risk, high-reward strategy, potentially amplifying both gains and losses. This approach positions CIMG as a unique player in the market, but also introduces significant governance and regulatory challenges.

What we're watching

Bitcoin Volatility
The company's substantial Bitcoin holdings expose it to significant price volatility, which could dramatically impact its asset base and financial performance. Continued reliance on Bitcoin as a core asset requires careful risk management.
China Regulatory Risk
Operating in China introduces regulatory and legal risks that could impede growth and profitability. Increased scrutiny of digital health and cryptocurrency businesses in China warrants close monitoring.
Contract Execution
The company's revenue growth is heavily reliant on the successful execution of computing power and digital health contracts. Failure to deliver on these contracts could significantly impact future performance.

CIMG Acquires Biopharma Firm Daren in Diversification Play

Event summary

  • CIMG Inc. (Nasdaq: IMG) has entered into a definitive agreement to acquire 100% of Daren Business Technology Limited.
  • The acquisition consideration is approximately $40 million, to be paid in shares over a 3.5-year period contingent on Daren achieving revenue targets.
  • Daren, a Hong Kong-based enterprise, focuses on R&D, production, marketing, and technical services within the biomedicine sector.
  • Revenue targets for Daren include $29 million (April-Sept 2026), $71 million (Oct 2026-Sept 2027), $143 million (Oct 2027-Sept 2028), and $257 million (Oct 2028-Sept 2029).

The big picture

CIMG’s acquisition of Daren represents a significant strategic pivot away from its core digital health and cryptocurrency-focused business. The move into biopharmaceuticals, a sector experiencing substantial growth, suggests a desire to diversify revenue streams and capitalize on emerging market opportunities. However, the performance-based payment structure introduces considerable risk, and the integration of a traditional biomedicine firm into CIMG’s technology-driven model presents operational complexities.

What we're watching

Execution Risk
The success of this acquisition hinges on Daren’s ability to meet aggressive revenue targets; failure to do so will result in a reduction of the share consideration and potentially impact CIMG’s financial performance.
Integration Challenges
CIMG’s existing business model, centered on digital health and cryptocurrency-driven sales development, may face integration challenges with Daren’s more traditional biomedicine operations.
Regulatory Scrutiny
As CIMG expands into the biopharmaceutical industry, it will be subject to increased regulatory scrutiny and compliance requirements, potentially impacting operational costs and timelines.

CIMG Award Highlights Computing Power Pivot, $124M Contract Wins

Event summary

  • CIMG Inc. received the 2025 'High-Quality Listed Company Award' from the Caiwen Awards.
  • The award recognizes performance in business strategy upgrades and sustainable value creation across sectors including healthcare, technology, and retail.
  • CIMG shifted its computing power business to a core strategy in 2025.
  • The company secured $124 million in computing power contracts and framework agreements in Q4 2025.
  • CEO Alice Wang stated the award will be leveraged to deepen the focus on computing power and increase industrial investments.

The big picture

CIMG's strategic shift towards computing power represents a significant bet on a rapidly expanding market, particularly within the digital health sector. The award provides external validation of this direction, but the company's success hinges on its ability to execute on these new contracts and navigate the inherent risks associated with cryptocurrency-related ventures. The Caiwen Awards’ focus on sustainable value creation also signals a broader trend towards ESG considerations influencing investment decisions in the region.

What we're watching

Execution Risk
The realization of the $124 million in contracts will be critical to validating CIMG's strategic pivot and requires close monitoring of project delivery and client satisfaction.
Governance Dynamics
The Caiwen Awards selection criteria, emphasizing corporate governance, suggest increased scrutiny of CIMG's operational transparency and compliance practices moving forward.
Competitive Landscape
The company's reliance on AI and cryptocurrency technologies exposes it to evolving regulatory frameworks and intensifying competition within the digital health and sales development space.

CIMG Secures $2M Computing Power Contracts Amid China's AI Infrastructure Push

Event summary

  • CIMG Inc. announced five computing power equipment sales contracts totaling approximately $2 million, executed between December 2025 and January 2026.
  • The contracts involve computing servers and power electronic components, targeting cloud service providers and industrial enterprises.
  • The contracts were signed through CIMG's subsidiary, Beijing Xinmiao Shidai Technology Development Co., Ltd.
  • CIMG is focusing on 'scenario-based computing power solutions' offering end-to-end services.
  • CEO Alice Wang highlighted the strategic importance of computing power, comparing it to semiconductors and energy, in the context of China's 'East Data West Computing' strategy.

The big picture

CIMG's move into computing power hardware aligns with the broader trend of treating compute as a strategic resource, particularly within China's ambitious data infrastructure plans. The $2 million contract value, while modest, signals an attempt to expand beyond its core digital health and sales development business. The company's focus on 'scenario-based' solutions suggests an attempt to address the fragmented and complex needs of Chinese enterprises, but also introduces operational complexity and potential margin pressure.

What we're watching

China Strategy
The success of CIMG's strategy hinges on navigating China's 'East Data West Computing' initiative and potential regulatory shifts impacting data center infrastructure deployment.
Service Model
Whether CIMG can effectively scale its 'scenario-based computing power solutions' and end-to-end services beyond the initial contracts will be crucial for sustained revenue generation.
Competition
The competitive landscape for computing power infrastructure services in China is intensifying; CIMG's ability to differentiate through specialized solutions will determine its market share.

CIMG Secures $2.6 Million Wood Chip Contract Amid Compliance Concerns

Event summary

  • CIMG Inc.'s subsidiary, Shenzhen Zhimeng Qiyang Technology Co., Ltd., signed a $2.59 million sales agreement with Zhangzhou Yuncheng Trading Co. for approximately 15,000 bone-dry metric tons of wood chips.
  • Delivery is expected to be completed by February 28, 2026, with a potential 10% variance in the wood chip quantity.
  • CIMG is currently facing issues related to the delayed submission of its annual report, impacting its compliance with Nasdaq listing requirements.
  • The contract is intended to stabilize CIMG’s raw material supply chain and positively impact financial performance.

The big picture

This contract, while relatively small in the context of CIMG’s overall business, signals an attempt to diversify revenue streams and secure raw material supply. The concurrent announcement of a delayed annual report filing raises concerns about corporate governance and potential regulatory scrutiny, potentially overshadowing the positive impact of the new contract. CIMG’s unusual business model, blending digital health, sales development, and cryptocurrency, makes its strategic direction and financial performance particularly complex to assess.

What we're watching

Governance Dynamics
The company's ability to swiftly resolve the annual report filing delay and regain compliance with Nasdaq listing requirements will be a key indicator of board oversight and investor confidence.
Execution Risk
The successful and timely completion of the wood chip delivery, within the agreed-upon variance, will be crucial to validating the stability of the new supply chain.
Strategic Diversification
How CIMG integrates this raw material supply chain activity with its core digital health and cryptocurrency-focused business lines will reveal the depth of its diversification strategy.

CIMG's Baijiu Brand Wins Award, Signals Expansion into Wellness

Event summary

  • CIMG Inc.'s Huo Mao baijiu brand received the "2025 China New Consumption Craftsmanship Heritage Award" from iiMedia Research.
  • The award recognizes Huo Mao's integration of traditional brewing techniques with modern technology, including the infusion of dendrobium.
  • CIMG's CEO, Alice Wang, highlighted the company's focus on medicinal food homology and expansion into health and wellness products.
  • CIMG operates a business group specializing in digital health and sales development, leveraging AI and cryptocurrencies.

The big picture

The award for Huo Mao highlights CIMG's strategy of blending traditional Chinese practices with modern technology to create premium consumer products. This approach, combined with the company’s unusual cryptocurrency-focused business model, positions CIMG as a unique player in the increasingly competitive Chinese consumer market. The company's stated expansion into health and wellness products suggests a broader ambition to leverage its digital capabilities across multiple sectors, but also introduces new operational and regulatory challenges.

What we're watching

Product Diversification
The company's stated focus on health and wellness products beyond baijiu presents execution risk; success hinges on CIMG’s ability to translate its digital health expertise into new product categories.
Regulatory Scrutiny
The integration of medicinal food homology into product development could attract increased regulatory scrutiny, particularly as CIMG expands into global markets.
Cryptocurrency Exposure
CIMG’s reliance on cryptocurrencies to drive business growth exposes the company to significant volatility and regulatory uncertainty within the digital asset space.
CID: 2817